The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: An autopsy study of 355 patients

Medicine

Volumn 77, Issue 4, 1998, Pages 246-254

  Van Burik, Jo Anne H ^a,b   Leisenring, Wendy ^a   Myerson, David ^a   Hackman, Robert C ^a   Shulman, Howard M ^a   Sale, George E ^a   Bowden, Raleigh A ^a   McDonald, George B ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ASPERGILLUS; AUTOPSY; BONE MARROW TRANSPLANTATION; CANDIDA; CANDIDIASIS; CHILD; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; LIVER ABSCESS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; AUTOPSY; BONE MARROW TRANSPLANTATION; CANDIDIASIS; COHORT STUDIES; FEMALE; FLUCONAZOLE; GRAFT VS HOST DISEASE; HUMANS; LIVER; MALE; PREMEDICATION; RETROSPECTIVE STUDIES;

EID: 0031845924     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199807000-00003     Document Type: Review

References (49)

1. Anaissie E, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 91: 142-50, 1991.
2. Anttila VJ, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Hepatosplenic candidiasis in patients with acute leukemia; Incidence and prognostic implications. Clin Infect Dis 24: 375-80, 1997.
3. Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED. Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60: 714-20, 1982.
4. Baily GG, Perry FM, Denning DW, Mandai BK. Fluconazole-resistant candidosis in an HIV cohort. AIDS 8: 787-92, 1994.
5. Besnard M, Hartmann O, Valteau-Couanet D, Robert MC, Brugieres L, Lemerle J. Systemic Candida infection in pediatric bone marrow autotransplantation: Clinical signs, outcome and prognosis. Bone Marrow Transplant 11: 465-70, 1993.
6. Bjerke JW, Meyers JD, Bowden RA. Hepatosplenic candidiasis - a contraindication to marrow transplantation? Blood 84: 2811-14, 1994.
7. Blazquez R, Berenguer J, Sanchez-Carrillo C, Alvarez E, Bouza E. Fungal infections found during autopsies: A report from Spain. Clin Infect Dis 20: 479-80, 1995.
8. Bodey G, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S, Naoe S, Okudaira M, Scevola D, van't Wout J. Fungal infections in cancer patients: An international autopsy survey. Eur J Clin Microbiol Infect Dis 11: 99-109, 1992.
9. Ferretti GA, Ash RC, Brown AT, Parr MD, Romond EH, Lillich TT. Control of oral mucositis and candidiasis in marrow transplantation: A prospective, double-blind trial of chlorhexidine digluconate oral rinse. Bone Marrow Transplant 3: 483-93, 1988.
10. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ, Powderly WG, Silber JL, Horowitz H, Lichtin A, Wolff SN, Mangan KF, Silver SM, Weisdorf D, Ho WG, Gilbert G, Buell D. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326: 845-51, 1992.
11. Goodrich JM, Reed EC, Mori M, Fisher LD, Skerrett S, Dandliker PS, Klis B, Counts GW, Meyers JD. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis 164: 731-40, 1991.
12. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 19: 402-8, 1994.
13. Hofstra W, de Vries-Hospers HG, van der Waaij D. Concentrations of nystatin in feces after oral administration of various doses of nystatin. Infection 7: 166-70, 1979.
14. Hofstra W, de Vries-Hospers HG, van der Waaij D. Concentrations of amphotericin B in feces and blood of healthy volunteers after the oral administration of various doses. Infection 10: 223-27, 1982.
15. Hoppe JE, Klingebiel T, Niethammer D. Selection of Candida glabrata in pediatric bone marrow transplant recipients receiving fluconazole. Ped Hemat Oncol 11: 207-10, 1994.
16. Kauffman CA, Bradley SF, Ross SC, Weber DR. Hepatosplenic candidiasis: Successful treatment with fluconazole. Am J Med 91: 137-41, 1991.
17. Klingspor L, Stintzing G, Fasth A, Tollemar J. Deep Candida infection in children receiving allogeneic bone marrow transplants: Incidence, risk factors and diagnosis. Bone Marrow Transplant 17: 1043-49, 1996.
18. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M, Lee N, Peters C, Comito M, Huling D, Trigg M. Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery. Blood 88: 1089-97, 1996.
19. Kunova A, Trupl J, Dluholucky S, Galova G, Krcmery V Jr. Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species. Clin Infect Dis 21: 226-27, 1995.
20. Lum LG, Seigneuret MC, Storb RF, Witherspoon RP, Thomas ED. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. Blood 58: 431-39, 1981.
21. Marr KA, Bowden RA, van Burik J-A, White TC. Development of a fluconazole-resistant Candida albicans in a patient undergoing bone marrow transplantation. Clin Infect Dis 25: 908-10, 1998.
22. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE, Sullivan KM, Storb R, Thomas ED, Witherspoon RP, Lomen P, Hannigan J, Hansen JA. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76: 1464-72, 1990.
23. Martino P, Girmenia C, Micozzi A, De Bernardis F, Boccancra M, Cassone A. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. Eur J Clin Microbiol Infect Dis 13: 797-804, 1994.
24. Martino P, Girmenia C, Venditti M, Micozzi A, Santilli S, Burgio VL, Mandelli F. Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64: 2030-34, 1989.
25. Milliken ST, Powles RL. Antifungal prophylaxis in bone marrow transplantation. Rev Infect Dis 12: S374-79, 1990.
26. Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C, Geller R, Wingard JR. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chem 41: 196-99, 1997.
27. Odds FC, Kibbler CC, Walker E, Bhamra A, Prentice HG, Noone P. Carriage of Candida species and C. albicans biotypes in patients undergoing chemotherapy or bone marrow transplantation for hematological disease. J Clin Pathol 42: 1259-66, 1989.
28. O'Donnell M, Schmidt GM, Tegtmeier BR, Faucett C, Fahey JL, Ito J, Nademanee A, Niland J, Parker P, Smith EP, Snyder DS, Stein AS, Blume KG, Forman SJ. Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 12: 827-34, 1994.
29. Persons DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida krusei fungemia. N Engl J Med 325: 1315, 1991.
30. Redding S, Smith J, Farinacci G, Rinaldi M, Fothergill A, Rhine-Chalberg J, Pfaller M. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: Documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 18: 240-42, 1994.
31. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemo 39: 11-18, 1995.
32. Rossetti F, Brawner DL, Bowden R, Meyer WG, Schoch WG, Fisher L, Myerson D, Hackman RC, Shulman HM, Sale GE, Meyers JD, McDonald GB. Fungal liver infection in marrow transplant patients: Prevalence at autopsy, predisposing factors, and clinical features. Clin Infect Dis 20: 801-11, 1995.
33. Schmidt U, Pfaffenbach B, Quabeck K, Donhuijsen K. Fungal infections after bone marrow transplantation - an autopsy study. Mycoses 1: 33-35, 1991.
34. Siadak M, Sullivan KM. The management of chronic graft-versus-host disease. Blood Rev 8: 154-60, 1994.
35. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA. Efficacy and safety of fluconazole for fungal infections after marrow transplant - a prospective, randomized, double-blind study. J Infect Dis 171: 1545-52, 1995.
36. Storb R, Witherspoon R. Marrow transplantation: What determines success or failure of hematologic reconstitution? Onkologie 10: 166-71, 1987.
37. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 16: 413-25, 1995.
38. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73: 1720-28, 1989.
39. Tam JY, Blume KG, Prober CG. Prophylactic fluconazole and Candida krusei infections. N Engl J Med 326: 891-92, 1991.
40. Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: The evolving picture of the syndrome. Ann Intern Med 108: 88-100, 1988.
41. Venkateswarlu K, Denning DW, Manning NJ, Kelly SL. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microbiol Lett 131: 337-41, 1995.
42. Verdeguer A, Fernandez JM, Esquembre C, Ferris J, Ruiz JG, Castel V. Hepatosplenic candidiasis in children with acute leukemia. Cancer 65: 874-77, 1990.
43. Verfaillie C, Weisdorf D, Haake R, Hostetter M, Ramsay NK, McGlave P. Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 8: 177-84, 1991.
44. Wald A, Leisenring W, van Burik J-A, Bowden RA. Natural history of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175: 1459-66, 1997.
45. Wingard JR. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin Infect Dis 19(Suppl 1): S49-53, 1994.
46. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20: 115-25, 1995.
47. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 324: 1274-77, 1991.
48. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chem 37: 1847-49, 1994.
49. Witherspoon R, Noel D, Storb R, Ochs HD, Thomas ED. The effect of graft-versus-host disease on reconstitution of the immune system following marrow transplantation for aplastic anemia or leukemia. Transplant Proc 10: 233-35, 1978.